38
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Anti-Inflammatory Effect of Interleukin-10 in Rabbit Immune Complex-Induced Colitis

Pages 754-758 | Published online: 08 Jul 2009

References

  • De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of il-10 produced by monocytes. J Exp Med 1991; 174: 1209–20.
  • Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. Il-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–22.
  • Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mossmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165–90.
  • O’Garra A, Chang R, Go N, Hastings R, Houghton G, Howard M. Ly-1 B (B-1) cells are the main source of B-cell derived interleukin-10. Eur J Immunol 1992; 22: 711–7.
  • Yssel H, De Waal Malefyt R, Roncarolo M-G, Abrams JS, Lahesmaa R, Spits H, et al. Il-10 is produced by subsets of human CD4+ T-cell clones and peripheral blood T-cells. J Immunol 1992; 149: 2378–84.
  • Enk A, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149: 92–95.
  • Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M, Moore KW, et al. Il-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444–51.
  • de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–24.
  • Taga K, Tosato G. Il-10 inhibits human T cell proliferation and IL-2. J Immunol 1992; 148: 1143–8.
  • Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T-helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081–95.
  • Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207–11.
  • Kasama T, Strieter M, Lukacs N, Burdick M, Kunkel S. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152: 3559–69.
  • Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994; 83: 2678–83.
  • Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Macdermott RP, et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1993; 94: 174–81.
  • Schreiber S, Heinig T, Thiele H, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434–44.
  • Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–74.
  • Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of TH1 responses prevents inflammatory bowel diseases in SCID mice reconstituted with CD45RBhi Cd4+ T cells. Immunity 1994; 1: 553–62.
  • Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leucocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695–9.
  • Miyazaki I, Cheung RK, Dosch H-M, et al. Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 1993; 178: 439–47.
  • Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn’s disease. Gut 1989; 30: 835–8.
  • MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflammed human intestine. Clin Exp Immunol 1990; 81: 301–5.
  • Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease—enhanced production during active disease. Gut 1990; 31: 686–9.
  • Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 1995; 154: 3454–60.
  • Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993; 151: 5666–74.
  • Hogdson HJF, Potter BJ, Skinner J, Jewell DP. Immune-complex mediated colitis in rabbits. Gut 1978; 19: 225–32.
  • Zipser RD, Nast CC, Lee M, Kao HW, Duke R. In vivo production of leukotriene B4 and leukotriene C4 in rabbit colits. Gastroenterology 1987; 92: 33–9.
  • Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 1994; 265: 1095–8.
  • Trevani AS, Fontan PA, Andonegui GA, Isturiz MA, Geffner JR. Neutrophil chemotaxis induced by immune complexes. Clin Immunol Immunopathol 1995; 74: 107–11.
  • Krawisz JE, Sharon P, Stenson WF. Quantitive assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344–50.
  • Wallace JL. Eicosanoids. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 123–32.
  • Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991; 12: 349–52.
  • Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992; 31: 65–71.
  • Hack CE, Eerenberg-Belmer AJM, Hannema AJ, Out TA, Aalberse RC. Polyethylene glycol enhances the binding of C1q to circulating immune complexes. J Immunol Methods 1981; 44: 211–21.
  • Meenan J, Grool TA, Hommes DW, Dijkhuizen S, Kate ten FJW, Wood M, et al. Lexipafant (BB882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol 1996; 8: 569–73.
  • Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Buller HR, et al. Attenuation of rabbit colitis by neutrophil inhibitory factor, a novel β-integrin inhibitor. Scand J Gastroenterol 1996; 31: 1007–9.
  • Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007–9.
  • Ralph P, Nakoinz A, Sampson-Johannes A, Fong S, Lowe D, Min H, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992; 148: 808–14.
  • James S. Mucosal immune regulation. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 65–77.
  • Schreiber S, Raedler A, Stenson W, Macdermott P. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992; 21: 451–502.
  • Yamada T, Grisham MB. Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 133–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.